Patent: 10,040,783
✉ Email this page to a colleague
Summary for Patent: 10,040,783
| Title: | Prostaglandin receptor EP2 antagonists, derivatives, compositions, and uses related thereto |
| Abstract: | The disclosure relates to Prostaglandin receptor EP2 antagonists, derivatives, compositions, and methods related thereto. In certain embodiments, the disclosure relates to methods of treating or preventing conditions and diseases in which EP2 receptor activation has a physiological role, such as but not limited to, brain injury, inflammatory diseases, neuroinflammation after a seizure, pain, endometriosis, cancer, rheumatoid arthritis, skin inflammation, vascular inflammation, colitis, and neurological disorders by administering a pharmaceutical composition comprising a compound disclosed herein to a subject in need thereof. |
| Inventor(s): | Jiang; Jianxiong (Decatur, GA), Ganesh; Thota (Alpharetta, GA), Du; Yuhong (Atlanta, GA), Thepchatri; Pahk (Atlanta, GA), Quan; Yi (Decatur, GA), Dingledine; Ray J. (Atlanta, GA) |
| Assignee: | Emory University (Atlanta, GA) |
| Application Number: | 15/365,850 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,040,783
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. | COTAZYM | pancrelipase | Capsule, Delayed Release | 020580 | December 09, 1996 | ⤷ Start Trial | 2036-11-30 |
| Abbvie Inc. | CREON | pancrelipase | Capsule, Delayed Release | 020725 | April 30, 2009 | ⤷ Start Trial | 2036-11-30 |
| Abbvie Inc. | CREON | pancrelipase | Capsule, Delayed Release | 020725 | June 10, 2011 | ⤷ Start Trial | 2036-11-30 |
| Abbvie Inc. | CREON | pancrelipase | Capsule, Delayed Release | 020725 | March 14, 2013 | ⤷ Start Trial | 2036-11-30 |
| Digestive Care, Inc. | PERTZYE | pancrelipase | Capsule, Delayed Release | 022175 | May 17, 2012 | ⤷ Start Trial | 2036-11-30 |
| Digestive Care, Inc. | PERTZYE | pancrelipase | Capsule, Delayed Release | 022175 | October 06, 2016 | ⤷ Start Trial | 2036-11-30 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
